Friday, March 8, 2019
Medical News Today: The FDA approve esketamine nasal spray for severe depression
Federal regulators have approved the use of the new prescription nasal spray drug esketamine for depression that has not responded to other treatments.
Related Posts:
How to socialize in a pandemic
Coronavirus cases continue to rise in Kentucky; governor touches on many topics: testing, politics, schools, health disparities, etc.
Ky. coronavirus cases still up, with 289 reported Friday; another health-care worker has died of covid-19; how do we safely hug?
Upward trend accelerates as Beshear announces 319 new virus cases, most in more than a month, with 65% in Jefferson County
Allison Adams, longtime public-health official, is new vice president for public policy at Foundation for a Healthy Kentucky
0 comments:
Post a Comment